Fennec Pharmaceuticals Inc.

Ownership Transactions Reported by 13 Insiders

Symbol
FENC on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
Po Box 13628, 68 Tw Alexander Drive, Research Triangle Park, NC

Insiders trading volume in the past year

Fennec Pharmaceuticals Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Southpoint Capital Advisors LP 10%+ Owner $32.9M -$2.84M -7.95% Nov 18, 2025
Robert Andrade Chief Financial Officer $5.79M Dec 1, 2025
Rosty Raykov Director $4.73M -$942K -16.6% Dec 1, 2025
Chris Rallis Director $2.11M -$41.2K -1.92% Oct 10, 2025
Khalid Islam Director $1.77M Jun 3, 2025
Marco Brughera Director $1.7M Jun 3, 2025
Jeffrey S. Hackman Chief Executive Officer, Director $1.52M +$105K +7.41% May 16, 2025
Jodi Cook Director $1.1M Jun 3, 2025
Adrian Haigh Chief Operating Officer $832K May 16, 2024
Christiana Cioffi Chief Strategy Officer $635K Mar 28, 2025
Terry Evans Chief Commercial Officer $635K Mar 28, 2025
Pierre Sayad Chief Medical Officer $635K Mar 28, 2025
Shubh Goel Chief Commercial Officer Dec 20, 2021

Recent Insider Transactions by Companies or Individuals for Fennec Pharmaceuticals Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.